Cargando…

Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer

Microseminoprotein-beta (MSMB, MSMB) is an abundant secretory protein contributed by the prostate, and is implicated as a prostate cancer (PC) biomarker based on observations of its lower expression in cancerous cells compared with benign prostate epithelium. However, as the current literature on MS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sjöblom, Liisa, Saramäki, Outi, Annala, Matti, Leinonen, Katri, Nättinen, Janika, Tolonen, Teemu, Wahlfors, Tiina, Nykter, Matti, Bova, G. Steven, Schleutker, Johanna, Tammela, Teuvo L. J., Lilja, Hans, Visakorpi, Tapio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777373/ https://www.ncbi.nlm.nih.gov/pubmed/26939004 http://dx.doi.org/10.1371/journal.pone.0150241

Ejemplares similares

The expression of AURKA is androgen regulated in castration-resistant prostate cancer
por: Kivinummi, Kati, et al.
Publicado: (2017)

Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression
por: Latonen, Leena, et al.
Publicado: (2018)

Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer
por: Annala, Matti, et al.
Publicado: (2015)

DOT1L-HES6 fusion drives androgen independent growth in prostate cancer
por: Annala, Matti, et al.
Publicado: (2014)

Contribution of ARLTS1 Cys148Arg (T442C) Variant with Prostate Cancer Risk and ARLTS1 Function in Prostate Cancer Cells
por: Siltanen, Sanna, et al.
Publicado: (2011)

Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases
por: Kallio, Heini M. L., et al.
Publicado: (2018)

Inherited DNA Repair Gene Mutations in Men with Lethal Prostate Cancer
por: Rantapero, Tommi, et al.
Publicado: (2020)

Mapping of the chromosomal amplification 1p21-22 in bladder cancer
por: Scaravilli, Mauro, et al.
Publicado: (2014)

Epigenetically altered miR-193b targets cyclin D1 in prostate cancer
por: Kaukoniemi, Kirsi M, et al.
Publicado: (2015)

Integrated clinical, whole-genome, and transcriptome analysis of multisampled lethal metastatic prostate cancer
por: Bova, G. Steven, et al.
Publicado: (2016)

MiRNA Profiles in Lymphoblastoid Cell Lines of Finnish Prostate Cancer Families
por: Fischer, Daniel, et al.
Publicado: (2015)

Identification of long noncoding RNAs with aberrant expression in prostate cancer metastases
por: Sattari, Mina, et al.
Publicado: (2023)

Overall and worst gleason scores are equally good predictors of prostate cancer progression
por: Tolonen, Teemu T, et al.
Publicado: (2011)

PALB2 variants in hereditary and unselected Finnish Prostate cancer cases
por: Pakkanen, Sanna, et al.
Publicado: (2009)

Proteomics of prostate cancer – revealing how cancer cells master their messy genomes
por: Latonen, Leena, et al.
Publicado: (2018)

Three‐dimensional structures of avian beta‐microseminoproteins: insight from the chicken egg‐specific beta‐microseminoprotein 3 paralog
por: Coste, Franck, et al.
Publicado: (2021)

NMD and microRNA expression profiling of the HPCX1 locus reveal MAGEC1 as a candidate prostate cancer predisposition gene
por: Mattila, Henna, et al.
Publicado: (2011)

Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine
por: Nurminen, Anssi, et al.
Publicado: (2023)

Segmentum: a tool for copy number analysis of cancer genomes
por: Afyounian, Ebrahim, et al.
Publicado: (2017)

Adaptive and non-adaptive gene expression responses in prostate cancer during androgen deprivation
por: Nätkin, Reetta, et al.
Publicado: (2023)

Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas
por: Lehtinen, Birgitta, et al.
Publicado: (2017)

Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas
por: Granberg, Kirsi J, et al.
Publicado: (2017)

Correction: Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer
Publicado: (2016)

Feature-based analysis of mouse prostatic intraepithelial neoplasia in histological tissue sections
por: Ruusuvuori, Pekka, et al.
Publicado: (2016)

Comparison of iTRAQ and SWATH in a clinical study with multiple time points
por: Jylhä, Antti, et al.
Publicado: (2018)

A Linear Model for Transcription Factor Binding Affinity Prediction in Protein Binding Microarrays
por: Annala, Matti, et al.
Publicado: (2011)

Comparative analysis of tissue reconstruction algorithms for 3D histology
por: Kartasalo, Kimmo, et al.
Publicado: (2018)

Analysis of spatial heterogeneity in normal epithelium and preneoplastic alterations in mouse prostate tumor models
por: Valkonen, Mira, et al.
Publicado: (2017)

Assessing Interactions of Two Loci (rs4242382 and rs10486567) in Familial Prostate Cancer: Statistical Evaluation of Epistasis
por: Chen, Li-Sheng, et al.
Publicado: (2014)

Spatial analysis of histology in 3D: quantification and visualization of organ and tumor level tissue environment
por: Ruusuvuori, Pekka, et al.
Publicado: (2022)

Nonmalignant AR-positive prostate epithelial cells and cancer cells respond differently to androgen
por: Kukkonen, Konsta, et al.
Publicado: (2022)

CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations
por: Khanna, Anchit, et al.
Publicado: (2015)

Expression and ERG regulation of PIM kinases in prostate cancer
por: Eerola, Sini K., et al.
Publicado: (2021)

The rs10993994 Risk Allele for Prostate Cancer Results in Clinically Relevant Changes in Microseminoprotein-Beta Expression in Tissue and Urine
por: Whitaker, Hayley C., et al.
Publicado: (2010)

Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease
por: Sipeky, Csilla, et al.
Publicado: (2021)

The role of plasma microseminoprotein-beta in prostate cancer: an observational nested case–control and Mendelian randomization study in the European prospective investigation into cancer and nutrition
por: Smith Byrne, K, et al.
Publicado: (2019)

Combined Longitudinal Clinical and Autopsy Phenomic Assessment in Lethal Metastatic Prostate Cancer: Recommendations for Advancing Precision Medicine
por: Jasu, Juho, et al.
Publicado: (2021)

Urinary prostate-specific antigen and microseminoprotein-beta levels in men with and without prostate cancer: A prospective cohort study
por: Shrivastava, Prashant, et al.
Publicado: (2020)

Construction of therapeutically relevant human prostate epithelial fate map by utilising miRNA and mRNA microarray expression data
por: Rane, Jayant K, et al.
Publicado: (2015)

The Ubiquitin-Proteasome System Does Not Regulate the Degradation of Porcine β-Microseminoprotein during Sperm Capacitation
por: Tumova, Lucie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ubg1n9lf3tethrute0ah2k8i8u